Biocon Subsidiary Receives Nod To Use Cytosorb In Covid-19 Treatment May 26, 2020 A+ A- Print Email https://ift.tt/eA8V8J https://www.ndtv.com The licence will be effective until the COVID-19 outbreak is controlled in the country, the company said in a regulatory filing. from NDTV News - Topstories https://ift.tt/2M3KuBA via IFTTT Labels: NDTV News - Topstories
Post a Comment